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STIMULASI MAGNETIK TERDENYUT UNTUK RAWATAN MASALAH 
INKONTINENS URINARI JENIS STRES DALAM KALANGAN WANITA 
ABSTRAK 
 
 Stimulasi magnetik terdenyut (PMS) telah digunakan sebagai pilihan rawatan 
tanpa bedah untuk menangani masalah inkontinens urinari jenis stres (SUI) sejak 
tahun 1999 disebabkan faktor keselamatan, tidak invasif, dan prosedur rawatan yang 
mudah. Namun demikian, 'Fifth International Consultation on Incontinence' 
menekankan bahawa bukti kajian yang sedia ada adalah tidak mencukupi untuk 
membimbing sebarang cadangan tentang penggunaannya untuk menangani masalah 
inkontinens urinari, dan kajian klinikal terkawal yang berkualiti tinggi adalah 
diperlukan. Oleh yang demikian, kajian ini bertujuan menilai keberkesanan PMS 
untuk rawatan masalah inkontinens urinari. Sebelum kajian di atas dilaksanakan, 
kajian sistematik telah dijalankan untuk menilai bukti PMS yang sedia ada dalam 
rawatan pesakit yang didiagnosis mengalami masalah inkontinens urinari. Hasil 
kajian menunjukkan bahawa PMS mengurangkan simptom masalah inkontinens 
urinari dalam kalangan wanita untuk jangka masa pendek. Walau bagaimanapun, 
tanpa kajian klinikal berkualiti tinggi, kesesuaian PMS sebagai pilihan rawatan untuk 
menangani masalah inkontinens urinari masih diragui. Oleh itu, protokol kajian 
klinikal yang berkualiti tinggi direka untuk menangani batasan-batasan yang 
diperhatikan. Seterusnya, indeks yang digunakan untuk menilai kesan masalah 
inkontinens urinari ke atas kualiti hidup (International Consultation on Incontinence 
Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) dan International 
Consultation on Incontinence Questionnaire-Lower Urinary Tract Symptoms Quality 
of Life (ICIQ-LUTSqol)) dan fungsi seksual dikaji dari segi kesahan dan 
 xxviii 
kebolehpercayaan dalam populasi tempatan. Semua indeks didapati memuaskan dari 
segi kesahan dan kebolehpercayaan. Dalam tempoh kajian ini, juga dapat 
diperhatikan kekurangan minat ke atas fungsi seksual pasangan yang mempunyai 
masalah inkontinens urinari. Justeru, satu kajian keratan rentas telah dijalankan untuk 
mengkaji pengalaman seksual pasangan dengan atau tanpa masalah inkontinens 
urinari. Sebagai tambahan, kesan PMS terhadap fungsi seksual pasangan masalah 
inkontinens urinari turut dikaji. Penemuan awal mendapati bahawa rawatan masalah 
inkontinens urinari yang berkesan dapat juga menambahbaikkan fungsi seksual 
kedua-dua pasangan. Bahagian terakhir kajian in melibatkan suatu kajian klinikal 
rawak, uji kaji dubel-buta dengan kawalan plasebo. Dalam kajian ini, seramai 120 
orang pesakit yang menghadapi masalah inkontinens urinari diberi rawatan PMS 
aktif atau plasebo secara rawak selama 8 minggu. Keberkesanan rawatan ini dinilai 
dengan menggunakan indeks ICIQ-UI SF. PMS aktif didapati 3.5 kali lebih berkesan 
dalam mengurangkan simptom masalah inkontinens urinari berbanding plasebo. 
Sepanjang tempoh susulan selama satu tahun, kajian ini menunjukkan bahawa faedah 
tersebut dapat dikekalkan untuk jangkamasa tertentu. PMS menunjukkan faedah 
jangka panjang yang menggalakkan, penerimaan pesakit yang tinggi, pengalaman 
yang positif dan kadar keciciran yang rendah. Oleh itu, rawatan ini merupakan 
pilihan rawatan tanpa bedah yang menarik dan memberangsangkan untuk pesakit 
yang tidak ingin menjalani pembedahan. 
 
 
 
 
 
 xxix 
PULSED MAGNETIC STIMULATION IN THE TREATMENT OF STRESS 
URINARY INCONTINENCE IN FEMALE SUBJECTS  
ABSTRACT 
 
 Pulsed magnetic stimulation (PMS) has been used as a non-surgical option 
for stress urinary incontinence (SUI) since 1999 due to its established safety, non-
invasiveness and simplicity of treatment procedures. However, the Fifth International 
Consultation on Incontinence (ICI) emphasised that the current evidence is 
insufficient to guide any recommendation on its use for urinary incontinence, and 
that well-powered randomised controlled trials are needed. Hence, the present study 
aimed to evaluate the efficacy of PMS for SUI in a randomized, double-blind, sham-
controlled trial. Prior to the above study, a systematic review was conducted to 
appraise existing evidence on PMS for patients with urinary incontinence. The 
results showed that PMS provided short-term improvement for incontinence 
symptoms in women. However, in the absence of high quality trials, the applicability 
of PMS as a treatment option for urinary incontinence remained uncertain. Thus, a 
high-quality clinical trial protocol was designed to address the key limitations noted. 
In the next part of the study, the questionnaires used to assess impact of SUI on 
quality of life (International Consultation on Incontinence Questionnaire-Urinary 
Incontinence Short Form (ICIQ-UI SF) and International Consultation on 
Incontinence Questionnaire- Lower Urinary Tract Symptoms Quality of Life (ICIQ-
LUTSqol)) and sexual function (Golombok Rust Inventory on Sexual Satisfaction 
(GRISS)) were evaluated for their validity and reliability in the local population. All 
questionnaires demonstrated satisfactory validity and reliability. During the study 
period, a lack of interest on sexual function of couples with incontinence partners 
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was noted. Thus, a cross-sectional survey was conducted to investigate sexual 
experience of couples with or without SUI partners. Additionally, the effects of PMS 
on sexual function of SUI couples were also studied. The preliminary findings 
suggested that effective treatment of female's SUI symptoms using PMS resulted in 
simultaneous improvement in the sexual function of both partners. In the final part of 
the study, a multicenter, randomized, double-blind, sham-controlled trial was 
conducted. A total of 120 female SUI subject were randomized to receive either 
active or sham PMS for 8 weeks. Treatment efficacy was assessed primarily using 
the ICIQ-UI SF score. Active PMS was found to be 3.5 times more likely to improve 
SUI symptoms compared with sham. During an additional 1-year of follow-up, the 
present findings showed that such benefits were sustained over time. The 
encouraging long-term response rates, high patient acceptance, desirable experience 
and low dropout rates suggested that PMS is an attractive and promising non-surgical 
alternative to patients who do not want to undergo surgery. 
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CHAPTER 1 STRESS URINARY INCONTINENCE 
 
1.1 INTRODUCTION 
Urinary incontinence (UI) is a common problem encompassing a constellation of 
symptoms. It affects the physical, psychological, social and economic well-being of 
affected individuals and their families (Coyne et al., 2012, Abrams et al., 2015, Su et 
al., 2015). Recent epidemiological studies have shown that UI affects 25% to 45% of 
the female population worldwide, with a prevalence of 10% to 40% in Malaysia 
(Dhillon et al., 2006, Low et al., 2006, Mohd Sidik, 2010, Milsom et al., 2013). This 
condition is characterised by complaint of involuntary leakage of urine, which should 
be distinguished from sweating or vaginal discharge. 
 
Although not life-threatening, UI poses negative impacts on all strata of the society 
and results in various social and medical ramifications. Patients usually continue to 
endure the life-disrupting consequences as it is often under-diagnosed, overlooked 
and seldom intervened. In Malaysia, patients are traditionally more conservative and 
more likely to be hesitant in seeking professional help, with ignorance being the 
main reason (Low et al., 2006). It is thus necessary to create awareness amongst the 
population that UI is largely treatable and they should always seek professional help 
for their UI and other related symptoms. 
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1.2 DEFINITION AND CLASSIFICATIONS OF URINARY INCONTINENCE 
The International Urogynaecological Association (IUGA)/International Continence 
Society (ICS) defines UI as the complaint of involuntary loss of urine. The three 
most common types of UI (Haylen et al., 2010, Staskin et al., 2013) affecting patients 
are:  
i) Stress urinary incontinence (SUI) 
SUI is the complaint of involuntary loss of urine on effort or physical exertion (e.g., 
sporting activities), or on sneezing or coughing. 
ii) Urgency urinary incontinence (UUI) 
UUI is the complaint of involuntary loss of urine associated with urgency. 
iii) Mixed urinary incontinence (MUI) 
MUI is the complaint of involuntary loss of urine associated with urgency and also 
with effort or physical exertion or on sneezing or coughing. 
 
Other less common categories of UI (Haylen et al., 2010, Staskin et al., 2013) 
include: 
i) Postural (urinary) incontinence 
Postural (urinary) incontinence is the complaint of involuntary loss of urine 
associated with change of body position, for example, rising from a seated or lying 
position. 
ii) Nocturnal enuresis 
Nocturnal enuresis is the complaint of involuntary loss of urine which occurs during 
sleep. 
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iii) Continuous urinary incontinence 
Continuous urinary incontinence is the complaint of continuous involuntary loss of 
urine. 
iv) Insensible urinary incontinence 
Insensible urinary incontinence is the complaint of UI where the woman has been 
unaware of how it occurred. 
v) Coital incontinence 
Coital incontinence is the complaint of involuntary loss of urine with coitus. This 
symptom might be further divided into that occurring with penetration or 
intromission and that occurring at orgasm. 
vi) Incontinence associated with chronic retention of urine 
Incontinence associated with chronic retention of urine is the complaint of 
involuntary loss of urine which occurs in conditions where the bladder does not 
empty completely as indicated by a significantly high residual urine volume and/or a 
non-painful bladder which remains palpable or percussable after the individual has 
passed urine. 
vii) Functional incontinence 
Functional incontinence is the complaint of involuntary loss of urine that results from 
an inability to reach the toilet due to cognitive, functional or mobility impairments in 
the presence of an intact lower urinary tract system. 
vii) Multi-factorial incontinence 
Multi-factorial incontinence is the complaint of involuntary loss of urine related to 
multiple interacting risk factors, including factors both within and outside the lower 
urinary tract such as co-morbidity, medication, age-related physiological changes and 
environmental factors. 
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1.3 BASIC ANATOMY, HISTOLOGY AND PHYSIOLOGY RELATED TO 
PELVIC FLOOR MUSCLE 
The pelvic floor consists of the levator ani muscles, the coccygeus muscles, and 
associated connective tissue which span the area underneath the pelvis (Figure 1.1). 
The pelvic floor has two hiatuses; anteriorly the urogenital hiatus which allow the 
urogenital apparatus (urethra and vagina) to pass through the pelvic floor into the 
perineum below and posteriorly rectal hiatus through which the anal canal passes. 
 
The levator ani can be traditionally divided into three sets of fibres according to its 
bony attachments and muscle fibre direction (Chapple and Milsom, 2012): 
 the pubococcygeus muscles which attaches from the pubis and extends to the 
coccyx at the back 
 the puborectalis muscles which surrounds the rectum connecting the pubic 
bones anteriorly in a U-shaped configuration, and 
 the iliococcygeus muscles which arises laterally from the arcus tendinous 
levator ani and forms a horizontal sheet that spans the posterior opening of 
the pelvis, providing a shelf on which the pelvic organs lie. 
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Figure 1.1 Disposition of the levator ani. (Adapted from Chapple and Milsom, 2012) 
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The levator ani contains not only type I fibres providing resting tone but also type II 
(fast-twitch) fibres that, under stress, maintain the urethral closure and prevent 
stretching of the pelvic ligaments (Chapple and Milsom, 2012). The pudendal nerve 
provides somatic innervation to the striated muscle of levator ani, as well as to the 
striated muscle within the external anal and urethral sphincters. The levator ani 
functions to support the pelvic fascia and keeps the rectum and vagina closed via 
sphincter closing action. It also acts by resisting rises in intra-pelvic pressure during 
any strain. 
 
Next, the urethra functions to provide an effective continence mechanism and to 
allow adequate and smooth emptying from the bladder. The urethral sphincter 
comprises two components including the external striated sphincter and the internal 
smooth sphincter. The properly functioning sphincters allow narrowing of the 
urethral space. The urethral mucosa and submucosa which occupies the urethral 
space function as a filler substance to help in securing closure of the urethral lumen 
(Wallner et al., 2009). The multifaceted interplay between the extrinsic continence 
mechanism and the intrinsic continence mechanism ensures that continence is 
achieved. The intrinsic continence mechanism is formed by contraction of these 
urethral sphincters while the extrinsic continence mechanism is created by the solid 
support system consisting of the pelvic floor muscles, organs and structures which 
surrounds the urethra. In the female, the levator ani muscles are situated lateral to the 
external sphincter while in the inferior parts of the external sphincter is firmly 
attached via a tendinous connection to the puborectalis muscles of the levator ani 
muscles (Plate 1.1). This attachment signifies that the urethral sphincter depends on 
the levator ani muscles for proper contraction and urethral closure. 
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Plate 1.1 The anatomical relationship of the external urethral sphincter (EUS) to the 
levator ani muscle (LAM) in adults. Panels (A) through (D) show transverse sections 
through the EUS and the LAM of an adult female (54 yr): (A) superior part of the 
EUS (arrowheads), section stained immunohistochemically for striated muscle; (B) 
sequential section stained with sirius red for connective tissue; (C) inferior part of the 
EUS (arrowheads), section stained immunohistochemically for striated muscle; (D) 
sequential section stained with sirius red for connective tissue. Note in (C) that in the 
adult, the anatomical relationship between the inferior part of the EUS and the LAM 
is still maintained. The contrast of images (A) and (C) was increased digitally. L = 
levator ani muscle; U = urethra; V = vagina. (Adapted from Wallner et al., 2009) 
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1.4 EPIDEMIOLOGY 
Despite an absence on a universal consensus on the definition of quality of life (QoL), 
the constitution of the World Health Organisation (WHO) defines health as "a state 
of complete physical, mental, and social well-being not merely the absence of 
disease" (WHO, 1948). Thus, it is imperative to acknowledge the general well-being 
of patients who seek treatment via assessing the improvement in their QoL rather 
than merely measuring changes in the severity of the disease. Although not a life-
threatening disease, SUI impairs patients' QoL considerably (Ragins et al., 2008). 
When compared to other diseases, UI was reported to reduce QoL, similar to severe 
chronic diseases such as stroke, arthritis, and chronic kidney disease (Schultz and 
Kopec, 2003, Horng et al., 2013). 
 
Various factors were found to predispose UI. These include (Hunskaar, 2008, 
Ebbesen et al., 2013, Milsom et al., 2013): 
 Increasing age. There is a steady increase in UI throughout the adult lifespan. 
 Obesity. It is one of the most clearly established risk factor for UI in women. 
 Pregnancy and parity 
 Mode of delivery. Vaginal delivery is significant risk factors for UI compared 
to caesarean section. 
 Hysterectomy. Hysterectomy by any route appears to be associated with 
development of subsequent UI symptoms, but the evidence is inconsistent. 
 Diabetes is a risk factor for UI although no mechanism has been established. 
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The prevalence of UI has been controversial, ranging from 5% to 69%, with most 
studies in United States of America and Europe reporting a prevalence of any UI in 
the range of 25% to 45% (Hannestad et al., 2000, Irwin et al., 2006, Milsom et al., 
2013). UI is at least twice as prevalent in women compared with men, and SUI 
accounts for about half of all incontinent cases in women. In Asia, the prevalence of 
SUI is 0.9% in Korean men and 20.7% in Korean women (Lee et al., 2011), 18% in 
the Taiwanese population (Chen et al., 2003) and 33% in the Japanese population 
(Ueda et al., 2000). The considerable variability in prevalence estimate is presumably 
attributed to confoundment in survey and epidemiological research, difference in 
definitions and measurements used, reporting bias as well as discrepancy in selection 
criteria and study population. Quantification of the true global impact is thus made 
difficult due to the heterogeneity of the available published data. 
 
The International Data Base population predicts that the worldwide population of age 
≥65 will increase by 160% between 2008 and 2040, with a steady elevation of life 
expectancy within the general population (Kinsella et al., 2009). Furthermore, the 
worldwide estimate of SUI is forecasted to rise by 20.7% to 167 million (by 2018), 
with the regional burden presumed to be the largest in Asia (Irwin et al., 2011). 
 
 
 
 
 
 
 
 10 
1.5 ETIOLOGY AND PATHOGENESIS OF STRESS URINARY 
INCONTINENCE 
As mentioned previously, the complex interplay between the extrinsic and intrinsic 
continence mechanism ensures that continence is achieved. The essential factors 
required for the urethra to remain closed at rest and during increased abdominal 
pressure include properly functioning sphincters, well-vascularised mucosa and 
submucosa and a healthy and intact vaginal wall support. 
 
The common causative factors of SUI are childbirth, injury to the urinary system and 
surgery of the pelvic area. During pregnancy, the pelvic structures undergo 
anatomical, hormonal and functional alterations. During the subsequent vaginal 
childbirth, the pelvic floor experiences momentous stretching, tearing and avulsion to 
make way for the newborn to go through it causing a longer and wider levator hiatus. 
A recent systematic review showed a pooled prevalence of 33% of any postpartum 
UI in the first three months postpartum, in which the prevalence was double in the 
vaginal delivery group (31%) compared to the caesarean section group (15%) (Thom 
and Rortveit, 2010). Nevertheless, caesarean section no longer exhibited significant 
protective effects against UI after multiple deliveries (MacLennan et al., 2000, 
Rortveit et al., 2003). 
 
The mechanism underlying SUI is usually due to urethral hypermobility or intrinsic 
sphinteric deficiency (ISD), but often both coexist. In urethral hypermobility, the 
urethra fails to close when the pelvic floor muscles becomes weak, resulting in it 
moving too much (hypermobile). The primary urethral weaknesses in the functioning 
of the pelvic muscles is based on DeLancey's theory of urethral support, the so-called 
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hammock theory (DeLancey, 1994, DeLancey, 1996). DeLancey found that the 
urethra lies in a position where it can be compressed against like a hammock layer on 
which the bladder and urethra rest. In this model, it is suggested that the urethra is 
compressed against the posterior position of the vagina, which provides a backboard 
against rises in the intra-abdominal pressure and thus prevent loss of urine. When the 
supporting structures is relaxed or lost, the bladder neck and urethra may encounter a 
rotational descent away from its retropubic position during periods of activity, 
resulting in increases in abdominal pressure. If the pressure of the bladder exceeds 
the pressure on the urethra, the urethra opens concomitantly, and leakage ensues. 
Surgical operations designed to stabilise or elevate the sub-urethral vaginal wall may 
help preserve continence (Richter et al., 2010, Mostafa et al., 2013, Khan et al., 
2015). 
 
ISD is a less common component of SUI focusing on the chronically weakened 
urethra characterised by low urethral closure pressure. In recent years, it became 
clear that urethral hypermobility and ISD are not mutually exclusive conditions 
(Chapple and Milsom, 2012). Urethral hypermobility may occur commonly without 
significant ISD, while ISD alone is rare, but there is typically a mixture of both in 
SUI patients. The paradigm shift away from simple categorisation of SUI followed in 
part because of the development of the concept of Valsalva leak point pressure and 
from the analysis of long-term results of SUI (McGuire, 1995, Leach et al., 1997). 
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1.6 DIAGNOSIS 
History 
The general history taking includes a detailed account from patients on any possible 
precipitating factors of urinary loss, time of onset and duration of symptoms and 
degree of bother, which should be characterised and quantified as accurately as 
possible (Staskin et al., 2013). The patient's medical history should include questions 
relevant to neurological and congenital abnormalities as well as information on 
previous urinary tract infections and pelvic surgery. The patient's medical history 
should provide information on menstrual status, obstetric history, medications which 
could possibly affect the lower urinary tract and any significant co-morbidities which 
can produce symptoms mimicking SUI.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 
Physical examination 
Physical examination should include abdominal, pelvic, perineal and a focused 
neurological examination, and showing incontinence when that is a complaint 
(Kobashi, 2012, Blaivas, 2000). Perineal examination allows description of the skin 
(such as presence of atrophic vaginitis, pelvic organ prolapse or any anatomic 
abnormalities). 
 
Pelvic organ prolapse (POP) 
POP is defined as the descent of one or more of the anterior vaginal wall, posterior 
vaginal wall, the uterus (cervix), or the apex of the vagina (vaginal vault or cuff scar 
after hysterectomy) (Abrams et al., 2002). The presence of any such sign should be 
correlated with relevant POP symptoms. More commonly, this correlation would 
occur at the level of the hymen or beyond, wherein the hymen is considered as the 
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fixed point of reference for prolapse description (Bump et al., 1996, Haylen et al., 
2010). 
 
POP can be divided into five stages (Figure 1.2): 
i) Stage 0: No prolapse is demonstrated. 
ii) Stage I: Most distal portion of the prolapse is more than 1 cm above the level of 
the hymen. 
iii) Stage II: Most distal portion of the prolapse is 1 cm or less proximal to or distal 
to the plane of the hymen. 
iv) Stage III: The most distal portion of the prolapse is more than 1 cm below the 
plane of the hymen. 
v) Stage IV: Complete eversion of the total length of the lower genital tract is 
demonstrated. 
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Figure 1.2 A,B: Prolapse staging—0, I, II, III, and IV (uterine—by the position of the 
leading edge of the cervix) (Haylen et al., 2010). 
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Urine analysis 
It is generally agreed that urine analysis is a fundamental test that should be carried 
out in the assessment of all incontinent patients (Kobashi, 2012). Urinary infections 
can simulate any lower urinary tract pathologic conditions including SUI. The value 
of urine analysis is exemplified by the findings that 60% of females without detrusor 
overactivity will develop detrusor overactivity at the time of urinary tract infection 
(Staskin et al., 2013). Furthermore, results from the urine analysis can help in 
identifying the presence of microbiota, pyuria, hematuria, proteinuria or glucosuria 
which can be suggestive of conditions that can cause secondary incontinence. 
 
Micturition diary 
The micturition time chart is an important self-monitored adjunct to medical history 
that records patients' voiding habits. Selected variables provide objective information 
on the incontinence episodes, pad use, fluid intake, distribution of voiding between 
daytime and night-time and each voided volume (Lose et al., 1998).  Nevertheless, 
the accuracy of micturition diary depends largely on the patient's ability to follow 
instructions and the reproducibility of this method may be questionable although it 
may improve with an increasing number of days of self-recording. 
 
Pad test 
The pad test quantifies the amount of urine lost over the duration of testing, by 
measuring the increase in the weight of the perineal pads (weighed pre- and post-
testing) used. This may serve as a guide to the severity of incontinence. Different 
durations from a short (20 minutes) test to a 24- and 48-hour tests have been used 
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with provocation varying from normal everyday activities to defined regimens (Lose 
et al., 1988, O'Sullivan et al., 2004, Wu et al., 2006). 
 
Pelvic floor muscle function 
Pelvic floor muscle function can be qualitatively defined by the tone at rest and the 
strength of a voluntary or reflex contraction classified as strong, normal or weak. 
Pelvic floor muscle contractions can be assessed by visual inspection, digital 
palpation, electromyography, dynamometry, perineometry, or ultrasound. Factors to 
be assessed include pelvic floor muscle strength, muscular endurance, repeatability, 
duration, coordination, and displacement (Haylen et al., 2010). 
 
The ICS reports in the standardisation of terminology of pelvic floor muscle function 
and dysfunction provides a fuller description of the assessment of pelvic floor muscle 
function including the following (Messelink et al., 2005): 
i) Normal pelvic floor muscles: Pelvic floor muscles which can voluntarily and 
involuntarily contract and relax. 
ii) Overactive pelvic floor muscles: Pelvic floor muscles which do not relax, or may 
even contract when relaxation is functionally needed, for example, during micturition 
or defecation. 
iii) Underactive pelvic floor muscles: Pelvic floor muscles which cannot voluntarily 
contract when this is appropriate. 
iv) Non-functioning pelvic floor muscles: Pelvic floor muscles where there is no 
action palpable. 
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Uroflowmetry and post void residual 
Uroflowmetry represents a simple non-invasive test to assess the emptying function 
of the bladder. Ideally, the uroflowmetry studies are conducted in a completely 
private uroflowmetry room. The patient voids into the uroflowmetry device when 
they have a normal but strong desire to empty their bladder. Various parameters are 
obtained from this test including patterns of urine flow, urine flow rate, voided 
volume, maximum and average flow rate, voiding time and time to maximum flow. 
The interpretation of the uroflowmetry results are best referenced to the Liverpool 
nomogram wherein under the 10th centile of the nomogram has been determined as 
having the most useful discriminatory ability for diagnosis of voiding difficulty 
(Haylen et al., 1989, Haylen et al., 2008) (Figure 1.3). A normal female voiding 
procedure is a bell-shaped curve on the uroflowmetry (Figure 1.4). 
 
The post-void residual urine volume (PVR) is defined as the volume of urine left in 
the bladder at the end of micturition (Abrams et al., 2002).  The ultrasonography 
provides an accurate estimate of the PVR (Lucas et al., 2012a). Clinicians generally 
consider a PVR of up to 50ml as normal, while a PVR of more than 200ml is 
regarded as problematic (Blaivas, 2000). A large PVR may be caused by either 
urethral obstruction or impaired detrusor contractility (Blaivas, 2000). 
 
 
 18 
 
Figure 1.3 Liverpool nomogram for maximum urine flow rate in women. Equation: 
Ln(maximum urine flow rate)=0.511 + 0.505 x Ln(voided volume); root mean 
square error=0.340 (Adapted from Haylen et al., 2008). 
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Figure 1.4 A schematic representation of urine flow over time (Haylen et al., 2010). 
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Urodynamic evaluation 
The urodynamic testing was developed as an extension of patient history and 
physical examination to objectively measure and document the entire lower urinary 
tract function especially when it can significantly change clinical diagnoses and have 
therapeutic consequences (Sirls et al., 2013). A urodynamic evaluation consists of 
filling cystometry and pressure flow study (voiding cystometry). 
 
Filling cystometry is the method by which the pressure/volume relationship of the 
bladder is measured during bladder filling (Abrams et al., 2002). It is an invasive test 
involving catheter placements into the bladder and another placed rectally or 
vaginally to measure abdominal pressure. The filling phase starts when filling 
commences and ends when the patient and urodynamicist decide that 'permission to 
void' has been given (Abrams et al., 2002). It can assess bladder sensation, bladder 
capacity, detrusor activity and bladder compliance. 
 
Pressure flow studies of voiding are the method by which the relationship between 
pressure in the bladder and urine flow rate is measure during bladder emptying 
(Abrams et al., 2002). The voiding phase starts when 'permission to void' is given or 
when uncontrollable voiding begins, and ends when the patient considers voiding has 
finished (Abrams et al., 2002). 
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1.7 OUTCOME MEASURES 
Scientific evaluation of outcome measures of therapeutic interventions is based on 
assessments conducted before and after treatment. Outcome measures are principally 
categorised as primary and secondary outcome measures. Primary outcome measures 
are those viewed by the researchers to be of central interest, and the anticipated 
changes are used to estimate sample size (Brubaker, 2013). There can be several 
secondary outcome measures which are not the main focus of the study objectives. 
These outcomes are seldom used in sample size calculations and are typically 
exploratory. Until a universal outcome tool has been established, multiple outcome 
measures that are valid and clinically relevant are intrinsic for assessment of SUI in 
clinical trials (Thuroff et al., 2011). 
 
Symptoms and health related quality of life 
It is crucial to assess multidimensional aspects of QoL. The two main types of health 
related QoL questionnaires include disease-specific and generic questionnaires. 
Disease-specific questionnaires measure one particular facet of health status such as 
symptoms (e.g. UI), social well-being (e.g. sexual function), psychological well-
being (e.g. depression) and cognitive function (e.g. mental status evaluation) 
(Brubaker, 2013). Examples of disease-specific questionnaires include the 
International Consultation on Incontinence Questionnaire-Urinary Incontinence 
Short Form (ICIQ-UI SF) (Avery et al., 2004), International Consultation on 
Incontinence Questionnaire- Lower Urinary Tract Symptoms Quality of Life (ICIQ-
LUTSqol) (Abrams et al., 2006), Urogenital Distress Inventory and Incontinence 
Impact Questionnaire (Shumaker et al., 1994). The generic questionnaires are 
designed to evaluate broad aspects of health across populations, rather than patients 
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with particular medical conditions. The relative insensitivity of generic measures on 
effect of urinary symptoms on QoL and on its improvement after treatment dictates 
the necessity to use both generic and condition-specific QoL measures in clinical 
trials. Examples include EQ-5D (Group, 1990), Patient Global Impression of 
Improvement (PGI-I) (Yalcin and Bump, 2003) and SF-36 (Brazier et al., 1992). 
 
Given the plethora of questionnaires available to assess the impact of UI on QoL, 
researchers and clinicians are often overwhelmed by multitude of options when 
selecting outcome measures. The International Consultation on Incontinence 
developed the ICI Modular Questionnaire project (ICIQ) with the aim to develop 
universally applicable standard guide for selection of questionnaire for use in clinical 
practice and research (Abrams et al., 2006, Coyne and Kelleher, 2010). The ICIQ-UI 
SF was developed as a brief and robust measure to assess the impact of symptoms of 
incontinence on QoL and treatment outcome. It consists of 4 items to assess the 
prevalence, frequency and perceived cause of UI, and its impact on everyday life. 
The ICIQ-UI SF has undergone extensive psychometric testing and is graded A 
(highly recommended by the International Consultation of Incontinence) as an 
outcome measure in research trials (Kelleher et al., 2013). The ICIQ-LUTSqol is a 
20-item questionnaire derived from the King's Health Questionnaire to assess in 
detail the impact of UI on patients' lives with particular reference to social effects. 
 
The PGI-I is single-item questionnaire comprising seven choices, ranging from "very 
much better" to "very much worse". Published data indicate that this single-item 
questionnaire is valid and reliable for assessment of baseline severity and treatment 
response in patients with SUI (Yalcin and Bump, 2003). 
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Micturition diary 
Symptoms relevant to SUI (incontinence episodes and complications) can be 
measured using a self-completed incontinence diary. However, accuracy is difficult 
to evaluate as there is no available gold standard against which the test results can be 
compared. Reproducibility depends on the parameter used, and improves with an 
increase in the number of days that the self-recording is obtained. Two or 3 days of 
recording (not necessarily consecutive) will generally provide more useful clinical 
data (Haylen et al., 2010). Similarly, it is recommended that a diary is kept for a 
minimum of three days as an outcome measure in clinical research (Lose et al., 
1998). 
 
Pad weighing tests 
Pad tests can be divided into short-term tests, generally performed under 
standardised conditions as office tests, and long-term tests, generally performed by 
the patient at home during 24 to 48 hours. Accuracy is difficult to assess. 
Reproducibility is generally poor, but improves if the circumstances are standardised 
as much as possible. A commonly used pad test is known as the one-hour pad test 
and should be conducted according to guideline as described by the International 
Continence Society (Abrams et al., 1988). For long-term tests, the test period should 
be sufficiently long (Lose et al., 1998).  
 
Pelvic muscle activity 
This is the force of voluntary pelvic muscle contraction determined in direct (e.g. 
digital or air pressure) or indirect (e.g. surface electromyography) measures (Lose et 
al., 1998). Several techniques have been proposed for the evaluation of the pelvic 
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floor muscle strength: digital palpation using various scoring systems, perineometry 
measuring intravaginal pressure or electromyographic (EMG) activity generated 
during a contraction and perineal ultrasound assessing elevation of the bladder neck 
during pelvic floor muscle contraction (Peschers et al., 2001). 
 
Uroflowmetry 
Maximum and average flow are directly dependent upon voided volume. 
Consequently, interpretation and comparison of flow rates require that the voided 
volume is taken into account. Flow rate depends to a lesser extent on age and sex, 
while parity, weight, menstrual cycle phase, or menopause status seem not to 
influence flow rate  Researchers should describe their methodology and provide 
reproducibility data or indicate their absence (Lose et al., 1998). 
 
Cystometry 
Cystometry variables include sensation, compliance, capacity, and activity of the 
bladder. The investigation can be carried out in a stationary or ambulatory setting. 
Data obtained are method-dependent. Accuracy is difficult to assess, since variation 
in various parameters is significant (Lose et al., 1998). 
 
Electromyography (EMG) 
EMG recordings are performed to examine the activity (behavior) of pelvic and 
sphincter muscles during different maneuvers, particularly during bladder filling and 
voiding (Lose et al., 1998). Both surface and intramuscular electrodes may be used 
for recording. The reliability of EMG recordings is poorly determined. 
 
